Severe COVID-19-associated myocarditis with cardiogenic shock - management with assist devices - a case report & review.
Stephanie NooneArmin N FlinspachStephan FichtlschererKai ZacharowskiMichael SonntagbauerFlorian Jürgen RaimannPublished in: BMC anesthesiology (2022)
The majority of patients required a combination of two assist devices to achieve sufficient cardiac output until recovery of left ventricular ejection fraction. Due to the rapid onset of this fulminant cardiogenic shock immediate invasive bridging therapy in a specialized center was lifesaving.
Keyphrases
- ejection fraction
- aortic stenosis
- left ventricular
- end stage renal disease
- sars cov
- coronavirus disease
- chronic kidney disease
- heart failure
- newly diagnosed
- acute myocardial infarction
- palliative care
- early onset
- prognostic factors
- hypertrophic cardiomyopathy
- transcatheter aortic valve replacement
- cardiac resynchronization therapy
- left atrial
- patient reported
- quantum dots